As per the Department of Pharmaceuticals, the sector has expanded its reach across the country while strengthening domestic production capabilities and innovation
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
Focus on preventive, tech-driven healthcare and digital ecosystem reforms under AB PM-JAY and ABDM
A nationwide network of over 1,000 accredited clinical trial sites will be created to accelerate drug development timelines and enhance research credibility
Early stage projects of up to Rs. 9 crore eligible for up to Rs. 5 crore assistance and later stage projects of up to Rs. 285 crore eligible for up to Rs. 100 crore assistance
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
This achievement is part of the population-based initiative for screening, prevention, and management of Non-Communicable Diseases
The scheme aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
The scheme is fully digitized and covers approximately 45% of India's population
Subscribe To Our Newsletter & Stay Updated
